Experimental quantification of transmission of genetically engineered pseudorabies virus

By Mulder W.A.M.   De Jong M.C.M.   Priem J.   Bouma A.   Pol J.M.A.   Kimman T.G.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1763-1769

Elsevier

Access to resources Recommend Favorite

Mechanisms of protection against simian immunodeficiency virus infection

By Johnson R.P.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1985-1987

Elsevier

Access to resources Recommend Favorite

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18

By Dunham S.P.   Flynn J.N.   Rigby M.A.   Macdonald J.   Bruce J.   Cannon C.   Golder M.C.   Hanlon L.   Harbour D.A.   Mackay N.A.   Spibey N.   Jarrett O.   Neil J.C.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1483-1496

Elsevier

Access to resources Recommend Favorite

Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene

By Sin J.-I.   Sung J.-H.   Suh Y.-S.   Lee A.-H.   Chung J.-H.   Sung Y.-C.  

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1827-1833

Elsevier

Access to resources Recommend Favorite

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H

By Tebbey P.W.   Scheuer C.A.   Peek J.A.   Zhu D.   LaPierre N.A.   Green B.A.   Phillips E.D.   Ibraghimov A.R.   Eldridge J.H.   Hancock G.E.  

Vaccine, Vol. 18, Iss. 24, 2000-06 ,pp. : 2723-2734

Elsevier

Access to resources Recommend Favorite